Table 1.
Median Candida auris Prevalence by Chicago Facility Type, May 2016 to December 2018
| Facility Type | Number of Facilities | Number of Surveys | C. auris Median Prevalencea (Range), % |
|---|---|---|---|
| Short-term acute-care hospitalb | 8 | 8 | 0 (0–14) |
| Long-term acute-care hospital | 4 | 18 | 31 (23–36) |
| Ventilator-capable skilled nursing facilityc | 3 | 18 | 66 (23–71) |
| Skilled nursing facilityb | 3 | 3 | 2 (0–2) |
Abbreviations: CPO, carbapenemase-producing organism; PPS, point prevalence survey.
a
Median prevalence and range were calculated using most recent PPS data from each facility. Candida auris and CPO prevalence was calculated as the number of patients screening positive plus the number of individuals previously known to be positive, divided by the total number of individuals listed on the ward or facility census on the day of the survey.
b
Excludes contact screening with <5 individuals screened on any unit or facility.
c
Data represent PPS conducted on ventilator-capable unit.